Drug Name: | Hyaluronidase (37326-33-3) |
---|---|
PubChem ID: | |
SMILES: | CC1(C(=C)N(C2=CC=CC=C21)CCCCCC(=O)O)C.Br |
InchiKey: | SVMKEDBUSSWSFY-UHFFFAOYSA-N |
Therapeutic Category: |
Molecular Weight (dalton) | : | 354.288 |
LogP | : | 4.5208 |
Ring Count | : | 1 |
Hydrogen Bond Acceptor Count | : | 2 |
Hydrogen Bond Donor Count | : | 1 |
Total Polar Surface Area | : | 40.54 |
This panel provides information on interacting drugs and their ADRs along with references
Interacting drug | Toxicity | Interaction Type | Mechanism | Reference |
---|
This panel provides drug-protein interaction and their ADRs along with references
Toxicity | Interacting Protein | Mechanism | Reference |
---|
This panel provides drug-food interactions and their ADRs along with references
Food | Toxicity | Reference |
---|
This panel provides information on metabolites and their ADRs along with references
Metabolite | Toxicity | Place of Metabolism | Mechanism | Reference |
---|
This panel provides information on drug category
Toxicity | Source |
---|---|
Anaphylactic Reaction | ADReCS |
Angioedema | ADReCS |
Erythema | ADReCS |
Hypersensitivity | ADReCS |
Oedema | ADReCS |
Pain | ADReCS |
Urticaria | ADReCS |